Overview

Effects of Chantix on Relapse Prevention for Smoking Cessation

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to validate an experimental paradigm to assess medication effects on smoking relapse following a brief (3-day) monitored period of smoking abstinence and a programmed cigarette lapse.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
AstraZeneca
Treatments:
Varenicline